April 3rd 2025
The move towards “pharma 4.0” requires a major shift, both ideologically and technologically, to adapt current processes to a framework that will automate much of today’s manufacturing.
The evolution of therapeutic modalities drives the adoption of single-use technologies.
Improving Intelligent Device Management
October 17th 2012Strategic management of intelligent devices is important in any processing field, and a new standards committee at the International Society of Automation aims to provide direction so that manufacturers can better utilize the devices' capabilities.
Early Development GMPs for Small-Molecule Specifications: An Industry Perspective (Part V)
IQ Consortium representatives explore and define common industry approaches and practices for applying GMPs in early development.
FLUID-BAG MULTI — superior logistics for liquid and semi-solid pharmaceutical products
October 2nd 2012Fluid-Bag Ltd provides comprehensive 900 and 1000 litre flexible IBC systems for liquid and semi-solid products, including filling and discharging equipment. The GMP compliant container system is designed to guarantee uniform liquid, maximise payload and minimise discharge residue (0.5% residue).
Seeking Solutions in Solid-State Chemistry
October 1st 2012The physical form of an API is an important consideration in formulation development. Particle-engineering technologies, such as crystal design for controlling crystallisation and producing cocrystals, particle-size reduction and amorphous solid dispersions, help to optimise delivery of a drug.
Bristol-Myers Squibb Issues Voluntary Recall of Carmustine for Overfilled Vials
September 4th 2012Bristol-Myers Squibb has initiated a voluntary recall of 10 lots of BiCNU (carmustine for injection) previously manufactured by Ben Venue Laboratories, a former, third-party contract manufacturer for the company, to the user level.